New combo therapy targets lung cancer brain spread in early trial
NCT ID NCT07304739
First seen Jan 07, 2026 · Last updated May 18, 2026 · Updated 20 times
Summary
This study tests a new treatment for people with a specific type of lung cancer (EGFR mutation-positive NSCLC) that has spread to the brain and its lining. The treatment combines a targeted drug (furmonertinib) with chemotherapy injected into the spinal fluid and precise radiation to the brain. The goal is to see if this combination can control the cancer in the brain longer. The study will enroll 30 adults who have not had prior treatment for advanced disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CANGZHOU People's Hospital
RECRUITINGCangzhou, Hebei, 061001, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Tianjin Huanhu Hospital
RECRUITINGTianjin, Tianjin Municipality, 300350, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Tianjin medical university cancer hospital and institute
RECRUITINGTianjin, Tianjin Municipality, 300060, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.